Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
May 03, 2018 10:16 AM ISTHere is a list of top five stocks which could give up to 15% return in the short term.
May 03, 2018 10:13 AM IST "Traders can accumulate the stock in the range of Rs 280-287 for the target of Rs 321 with a stop loss below Rs 269," says Achin Goel, Head of Wealth Management and Financial Planning at Bonanza Portfolio.
May 03, 2018 09:09 AM IST Rajesh Agarwal of AUM Capital recommends buying Container Corporation of India with stop loss at Rs 1300 and target at Rs 1357, a buy in EIH with stop loss at Rs 182 and target at Rs 200 and a buy also in Kansai Nerolac Paints with stop loss at Rs 493 and target at Rs 520.
Nov 06, 2017 10:05 AM IST Torrent Pharmaceuticals will acquire Unichem Laboratories' branded formulation business in India and Nepal for Rs 3,600 crore.
Nov 06, 2017 08:03 AM IST The deal marks the fifth acquisition for Torrent. In 2014, Torrent had acquired a set of Elder brands. In the past few years it has acquired manufacturing plants from ZygPharma and Glochem industries and few brands from Novartis.
Mar 20, 2017 03:14 PM IST Ashwani Gujral of ashwanigujral.com is of the view that one can buy Unichem Labs, Aurobindo Pharma and PC Jeweller.
Mar 10, 2017 11:09 AM IST 
Oct 20, 2016 09:26 AM IST Ashwani Gujral of ashwanigujral.com recommends buying GSFC, Century Plyboards, VIP Industries, Unichem Laboratories and Indiabulls Housing Finance.
Sep 23, 2016 12:37 PM IST Rajat Bose of rajatkbose.com is of the view that one may pick Bharat Financial Inclusion and Ujjivan Financial Services.
Jul 12, 2016 09:12 AM IST Ashwani Gujral of ashwanigujral.com recommends buying Bajaj Finance, Shriram Transport, Cox & Kings, Unichem Laboratories and Bank of Baroda.
Jun 22, 2016 03:28 PM IST Ashwani Gujral of ashwanigujral.com is of the view that one can buy Gujarat Heavy Chemicals, Unichem Laboratories and Natco Pharma.
May 20, 2016 05:57 PM IST SP Tulsian, sptulsian.com, talks about why he is bullish on Harita Seating and discusses the pharma stock and SpiceJet.
May 18, 2016 02:09 PM IST According to Ashwani Gujral of ashwanigujral.com, one can sell United Breweries and TCS and advises buying Unichem Laboratories.
Apr 27, 2016 03:13 PM IST Ashwani Gujral of ashwanigujral.com recommends buying Reliance Communications, Unichem Labs and Hindustan Unilever.
Oct 12, 2015 01:34 PM IST Here are a few top buzzing midcap stocks by CNBC-TV18's analysts for trade today - Vedanta, Zensar, Tata Steel, Motherson Sumi, Rural Electrification Corporation (REC), Power Finance Corporation (PFC), Tamil Nadu Newsprint and Papers Limited (TNPL), Arvind Infra, Bank of Baroda & Unichem Industries.
Sep 15, 2015 10:40 AM IST Prakash Diwan of prakashdiwan.in is bullish on Unichem Laboratories and feels that it is ripe for picking amongst the midcap pharmaceuticals. "One may look at Dishman Pharmaceuticals," he adds.
Feb 12, 2014 01:18 PM IST Sandeep Shenoy of Anand Rathi Financial Services is of the view that one may prefer Ipca Laboratories, Unichem Laboratories and Indoco Remedies from the pharma space.
Nov 25, 2013 12:18 PM IST Parag Thakkar, Head of Sales at HDFC Securities likes Birla Corporation, Unichem Laboratories and Goodyear India from midcap space.
Nov 18, 2013 05:20 PM IST Pritesh Mehta, senior technical analyst at IIFL recommends buying Unichem Laboratories as the stock may test Rs 220.
Jul 25, 2013 12:01 PM IST Prakash Diwan of Altamount Capital Management recommends going long on GMR Infrastructurewith a target price of Rs 17.25 and a stop loss of Rs 16.25 and go long on MindTree with a target price of Rs 991 and a stop loss of Rs 937.
Jul 25, 2013 09:00 AM IST Prakash Diwan of Altamount Capital Management recommended buying GMR Infrastructure with a target price of Rs 17.25 and Mindtree with a target price of Rs 991.
Feb 18, 2013 03:12 PM IST SP Tulsian, sptulsian.com is of the view that one can exit Unichem Laboratories at Rs 195. The company has sold their formulation unit to Mylan Laboratories for Rs 160 crore on a slump sale basis. So, that will definitely be improving their performance.
Oct 30, 2012 11:45 AM IST In CNBC-TV18's popular show Bull's Eye, Prakash Diwan of Prakash Diwan's Wealth Circle shares trading strategy of the day.
Oct 30, 2012 08:05 AM IST Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Aug 14, 2012 10:55 AM IST In CNBC-TV18's popular show Bull's Eye, Rajesh Agarwal, Eastern Financiers shares trading strategy of the day.
Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.
